New molecule shows early potential to repair myelin in MS
A preclinical study identifies CN045 as a lead small molecule that promotes maturation of oligodendrocyte progenitor cells (OPCs) into myelin-producing cells and modestly increases remyelination in a mouse model of MS, suggesting potential for a remyelination therapy but requiring optimization and later testing in people.